Alessa Therapeutics, Inc.
PrivateLast Round
VC Round
May 1, 2025
Total Funding Raised
$18.35M
Company Overview
Alessa Therapeutics, Inc. is a biotechnology company that develops proprietary localized drug delivery technology for the early interception and treatment of prostate cancer and other solid organ diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alessa Therapeutics, Inc. Comparables
Compare Alessa Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PanTher Therapeutics | 85% | |
| Postsurgical Therapeutics, Inc. | 80% | |
| NanOlogy, LLC | 79% |
Alessa Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 1, 2025 | ||||
| Seed | Dec 12, 2024 | ||||
| Grant | Aug 4, 2021 | ||||
| Seed | Mar 21, 2019 |
Key People
Founding team and executive leadership
Alessa Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioInnovation Capital | Seed |
| Mission BioCapital | VC Round, Seed |
| Cure Ventures | VC Round |
| Johnson & Johnson Innovation – JJDC | Seed |
| Johnson & Johnson Innovation - JJDC, Inc. | Seed |
| Mission Bay Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Will present at the 44th Annual J.P. Morgan Healthcare Conference.
- May 1, 2025
$25.4M raised with participation from Cure Ventures and Mission BioCapital.
Alessa Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alessa Therapeutics, Inc.'s valuation, stock price, and market status.
Is Alessa Therapeutics, Inc. a public or private company?
Alessa Therapeutics, Inc. is a private company.
What is the current stock price of Alessa Therapeutics, Inc.?
Alessa Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Alessa Therapeutics, Inc. worth (valuation)?
Valuation information for Alessa Therapeutics, Inc. is not publicly available.
Can I buy Alessa Therapeutics, Inc. stock?
Alessa Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alessa Therapeutics, Inc.'s last funding round?
Alessa Therapeutics, Inc.'s most recent funding round was Series A on April 30, 2025.
Who are the main investors in Alessa Therapeutics, Inc.?
Key investors in Alessa Therapeutics, Inc. include Mission BioCapital.
Will Alessa Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Alessa Therapeutics, Inc..
How can I track Alessa Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alessa Therapeutics, Inc.'s secondary market activity and sign up for updates.